Docline
PrivateLast Round
Series A
Oct 14, 2025
Total Funding Raised
$8.53M
Company Overview
Docline is a health technology company that provides a comprehensive telemedicine platform for healthcare professionals, hospitals, insurers, and pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, EHR & EMR, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Docline Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Docline Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 14, 2025 | ||||
| Seed | Jan 11, 2023 |
Key People
Founding team and executive leadership
Docline Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| sherry ventures | Seed |
| EmergingTech Ventures | Seed |
| Small Enterprise Assistance Funds | Seed |
| 212 Founders | Series A |
Docline Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Docline's valuation, stock price, and market status.